Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0038362 (
stomatitis
)
8,852
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We investigated the immunoregulatory properties of a recently described inhibitor of lymphocyte proliferation,
suppressin
(
SPN
). It was determined that preincubation of murine leukocytes with
SPN
enhances natural killer cell (NK) activity. In addition,
SPN
potentiates interferon-gamma (IFN-gamma) augmentation of NK activity. Furthermore, preincubation of murine leukocytes with
SPN
induces the production of IFN-alpha/beta. The IFN-alpha/beta produced is active in NK assays as well as vesicular
stomatitis
virus neutralization assays. In vivo,
SPN
increases the time of survival of C57BL/6 mice injected with EL-4 lymphoma cells. Interestingly,
SPN
inhibits immunoglobulin (IgA, IgG, and IgM) production in response to the mitogen, concanavalin A in a dose-dependent manner. Collectively, the above data indicate
SPN
may have numerous applications in clinical science including tumor surveillance and autoimmune diseases such as arthritis.
...
PMID:Immunomodulatory characteristics of a novel antiproliferative protein, suppressin. 212 98